Patents by Inventor Betzi ZAFRA

Betzi ZAFRA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250025233
    Abstract: A method that includes selectively positioning an ablation catheter system at a treatment site comprising cardiac tissue, ablating cardiac tissue at the treatment site with the ablation catheter system using a power setting of approximately 90 W applied to tissue for approximately four (4) seconds to achieve a target electrode temperature, and achieving approximately zero incidence of steam pop occurrence in both left and right atrial ablations and complete pulmonary vein isolation, by the ablation catheter system, for all patients of a predetermined patient population suffering from paroxysmal atrial fibrillation (PAF).
    Type: Application
    Filed: October 1, 2024
    Publication date: January 23, 2025
    Applicant: Biosense Webster (Israel) Ltd.
    Inventors: Reecha SHARMA, Robert B. STAGG, Zhong WANG, Betzi ZAFRA, Lee Ming BOO, Assaf GOVARI, Thomas V. SELKEE, Christopher Thomas BEECKLER, Andres Claudio ALTMANN, Joseph Thomas KEYES, Athanassios PAPAIOANNOU, Kristine B. FUIMAONO
  • Publication number: 20240407826
    Abstract: A method and an apparatus configured to perform the method, the method including selecting a first maximum radiofrequency (RF) power for a first ablation mode within a range of 70 W to 100 W and selecting a second maximum RF power for a second ablation mode within a range of 20 W to 60 W. The method also includes selecting a maximum allowable temperature, of tissue to be ablated in the first ablation mode, within a range of 55° C.-65° C., and selecting irrigation rates for providing irrigation fluid to the electrode in the first ablation mode and the second ablation mode within a range of 8-45 ml/min. In some embodiments, the first maximum RF power is 90 W applied for 4 seconds with a maximum temperature of 60° C.
    Type: Application
    Filed: August 22, 2024
    Publication date: December 12, 2024
    Applicant: Biosense Webster (Israel) Ltd.
    Inventors: Reecha SHARMA, Robert B. STAGG, Zhong WANG, Betzi ZAFRA, Lee Ming BOO, Assaf GOVARI, Thomas V. SELKEE, Christopher Thomas BEECKLER, Andres Claudio ALTMANN, Joseph Thomas KEYES, Athanassios PAPAIOANNOU, Kristine B. FUIMAONO
  • Patent number: 12108983
    Abstract: A method that includes selectively positioning an ablation catheter system at a treatment site; and ablating tissue at the treatment site with the ablation catheter system using a power setting of approximately 90W applied to tissue for approximately four (4) second increments with a break period of approximately 4 seconds between applications.
    Type: Grant
    Filed: November 15, 2021
    Date of Patent: October 8, 2024
    Assignee: Biosense Webster (Israel) Ltd.
    Inventors: Reecha Sharma, Robert B. Stagg, Zhong Wang, Betzi Zafra, Lee Ming Boo, Assaf Govari, Thomas V. Selkee, Christopher Thomas Beeckler, Andres Claudio Altmann, Joseph Thomas Keyes, Athanassios Papaioannou, Kristine B. Fuimaono
  • Publication number: 20220151693
    Abstract: A method that includes selectively positioning an ablation catheter system at a treatment site; and ablating tissue at the treatment site with the ablation catheter system using a power setting of approximately 90W applied to tissue for approximately four (4) second increments with a break period of approximately 4 seconds between applications.
    Type: Application
    Filed: November 15, 2021
    Publication date: May 19, 2022
    Applicant: Biosense Webster (Israel) Ltd.
    Inventors: Reecha SHARMA, Robert B. STAGG, Zhong WANG, Betzi ZAFRA, Lee Ming BOO, Assaf GOVARI, Thomas V. SELKEE, Christopher Thomas BEECKLER, Andres Claudio ALTMANN, Joseph Thomas KEYES, Athanassios PAPAIOANNOU, Kristine B. FUIMAONO
  • Patent number: 11172984
    Abstract: A method that includes selectively positioning an ablation catheter system at a treatment site; and ablating tissue at the treatment site with the ablation catheter system using a power setting of approximately 90 W applied to tissue for approximately four (4) second increments with a break period of approximately 4 seconds between applications.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: November 16, 2021
    Assignee: BIOSENSE WEBSTER (ISRAEL) LTD.
    Inventors: Reecha Sharma, Robert B. Stagg, Zhong Wang, Betzi Zafra, Lee Ming Boo, Assaf Govari, Thomas V. Selkee, Christopher Thomas Beeckler, Andres Claudio Altmann, Joseph Thomas Keyes, Athanassios Papaioannou, Kristine B. Fuimaono
  • Publication number: 20200345415
    Abstract: A method that includes selectively positioning an ablation catheter system at a treatment site; and ablating tissue at the treatment site with the ablation catheter system using a power setting of approximately 90W applied to tissue for approximately four (4) second increments with a break period of approximately 4 seconds between applications.
    Type: Application
    Filed: May 1, 2020
    Publication date: November 5, 2020
    Applicant: Biosense Webster (Israel) Ltd.
    Inventors: Reecha SHARMA, Robert B. STAGG, Zhong WANG, Betzi ZAFRA, Lee Ming BOO, Assaf GOVARI, Thomas V. SELKEE, Christopher Thomas BEECKLER, Andres Claudio ALTMANN, Joseph Thomas KEYES, Athanassios PAPAIOANNOU, Kristine B. FUIMAONO
  • Publication number: 20200305952
    Abstract: An ablation catheter system for drug refractory symptomatic paroxysmal atrial fibrillation (PAF). The system can include an elongated body; an electrode assembly comprising a shell configured with an inner chamber and a wall defining a proximal portion and a distal portion, the wall of the distal portion having at least one aperture; and a micro-element extending through the inner chamber between the proximal portion and the distal portion, the micro-element having a distal end received in the at least one aperture, the distal end being at least coextensive with an outer surface of the wall. The system is configured to achieve acute procedural PVI success for all patients of a predetermined patient population suffering from PAF.
    Type: Application
    Filed: May 4, 2020
    Publication date: October 1, 2020
    Applicant: Biosense Webster (Israel) Ltd.
    Inventors: Reecha SHARMA, Robert B. STAGG, Zhong WANG, Betzi ZAFRA, Lee Ming BOO, Assaf GOVARI, Thomas V. SELKEE, Christopher Thomas BEECKLER, Andres Claudio ALTMANN, Joseph Thomas KEYES, Athanassios PAPAIOANNOU, Kristine B. FUIMAONO